We therefore tested the in vivo efficacy of EBC-46 in BALB/c Foxn1nu mice xenografted with B16-F0 mouse melanoma cells via intra-tumoral injection in the presence or absence of bisindolylmaleimide-1, a PKC inhibitor. This evidence concerns the gene PRRT2 and melanoma.